AC Partners, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AC Partners, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $0 | Mar 20, 2012 |
| FY2011 | Dec 31, 2010 | $0 | Mar 20, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($193.8K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | ($2.10M) | Mar 31, 2015 |
| FY2014 | Dec 31, 2012 | ($7.66M) | Mar 31, 2015 |
| FY2014 | Dec 31, 2011 | ($632.6K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2010 | ($363.0K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2009 | ($253.5K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2008 | ($231.5K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2007 | ($47.7K) | Mar 31, 2015 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $2.05M | Mar 31, 2015 |
| FY2013 | Dec 31, 2013 | $2.05M | Apr 14, 2014 |
| FY2013 | Dec 31, 2012 | $945.1K | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | $384.1K | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | $307.9K | Mar 20, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $5.3K | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | $3.4K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | ($226.7K) | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | ($600.9K) | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | ($362.9K) | Mar 20, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $19.9K | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | $30.8K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $38.1K | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | $75.0K | Apr 15, 2013 |
| FY2011 | Dec 31, 2010 | $65.9K | Mar 20, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($1.17M) | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | ($1.07M) | Mar 31, 2015 |
| FY2014 | Dec 31, 2012 | ($928.8K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2011 | ($743.5K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2010 | $46.6K | Mar 31, 2015 |
| FY2014 | Dec 31, 2009 | ($253.0K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2008 | ($237.5K) | Mar 31, 2015 |
| FY2014 | Dec 31, 2007 | ($30.6K) | Mar 31, 2015 |
| FY2011 | Dec 31, 2006 | $0 | Mar 20, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | ($12.25M) | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | ($12.06M) | Mar 31, 2015 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $563 | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | $3.6K | Mar 31, 2015 |
| FY2014 | Dec 31, 2012 | $565 | Mar 31, 2015 |
| FY2011 | Dec 31, 2011 | $42.5K | Mar 20, 2012 |
| FY2011 | Dec 31, 2010 | $45.0K | Mar 20, 2012 |
| FY2011 | Dec 31, 2009 | $33.6K | Mar 20, 2012 |
| FY2011 | Sep 18, 2007 | $0 | Mar 20, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | 0 | Mar 20, 2012 |
| FY2011 | Dec 31, 2010 | (9,553) | Mar 20, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | 11.92M | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | 11.92M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 11.92M | Apr 14, 2014 |
| FY2012 | Dec 31, 2011 | 1.38M | Apr 15, 2013 |